141 related articles for article (PubMed ID: 34530344)
1. Th1 polarization in the tumor microenvironment upregulates the myeloid-derived suppressor-like function of macrophages.
Nonaka K; Saio M; Umemura N; Kikuchi A; Takahashi T; Osada S; Yoshida K
Cell Immunol; 2021 Nov; 369():104437. PubMed ID: 34530344
[TBL] [Abstract][Full Text] [Related]
2. Metabolomic profiling of tumor-infiltrating macrophages during tumor growth.
Umemura N; Sugimoto M; Kitoh Y; Saio M; Sakagami H
Cancer Immunol Immunother; 2020 Nov; 69(11):2357-2369. PubMed ID: 32518979
[TBL] [Abstract][Full Text] [Related]
3. Cognate Interaction With CD4
Eisel D; Das K; Dickes E; König R; Osen W; Eichmüller SB
Front Immunol; 2019; 10():219. PubMed ID: 30853959
[TBL] [Abstract][Full Text] [Related]
4. AMPK Alpha-1 Intrinsically Regulates the Function and Differentiation of Tumor Myeloid-Derived Suppressor Cells.
Trillo-Tinoco J; Sierra RA; Mohamed E; Cao Y; de Mingo-Pulido Á; Gilvary DL; Anadon CM; Costich TL; Wei S; Flores ER; Ruffell B; Conejo-Garcia JR; Rodriguez PC
Cancer Res; 2019 Oct; 79(19):5034-5047. PubMed ID: 31409640
[TBL] [Abstract][Full Text] [Related]
5. Folate Receptor Beta Designates Immunosuppressive Tumor-Associated Myeloid Cells That Can Be Reprogrammed with Folate-Targeted Drugs.
Cresswell GM; Wang B; Kischuk EM; Broman MM; Alfar RA; Vickman RE; Dimitrov DS; Kularatne SA; Sundaram CP; Singhal S; Eruslanov EB; Crist SA; Elzey BD; Ratliff TL; Low PS
Cancer Res; 2021 Feb; 81(3):671-684. PubMed ID: 33203700
[TBL] [Abstract][Full Text] [Related]
6. Metformin induces CD11b+-cell-mediated growth inhibition of an osteosarcoma: implications for metabolic reprogramming of myeloid cells and anti-tumor effects.
Uehara T; Eikawa S; Nishida M; Kunisada Y; Yoshida A; Fujiwara T; Kunisada T; Ozaki T; Udono H
Int Immunol; 2019 Mar; 31(4):187-198. PubMed ID: 30508092
[TBL] [Abstract][Full Text] [Related]
7. Targeting glutamine metabolism enhances tumor-specific immunity by modulating suppressive myeloid cells.
Oh MH; Sun IH; Zhao L; Leone RD; Sun IM; Xu W; Collins SL; Tam AJ; Blosser RL; Patel CH; Englert JM; Arwood ML; Wen J; Chan-Li Y; Tenora L; Majer P; Rais R; Slusher BS; Horton MR; Powell JD
J Clin Invest; 2020 Jul; 130(7):3865-3884. PubMed ID: 32324593
[TBL] [Abstract][Full Text] [Related]
8. Tumor cell-released autophagosomes (TRAPs) promote immunosuppression through induction of M2-like macrophages with increased expression of PD-L1.
Wen ZF; Liu H; Gao R; Zhou M; Ma J; Zhang Y; Zhao J; Chen Y; Zhang T; Huang F; Pan N; Zhang J; Fox BA; Hu HM; Wang LX
J Immunother Cancer; 2018 Dec; 6(1):151. PubMed ID: 30563569
[TBL] [Abstract][Full Text] [Related]
9. Chimeric antigen receptor T cells shape myeloid cell function within the tumor microenvironment through IFN-γ and GM-CSF.
Spear P; Barber A; Rynda-Apple A; Sentman CL
J Immunol; 2012 Jun; 188(12):6389-98. PubMed ID: 22586039
[TBL] [Abstract][Full Text] [Related]
10. Immunotherapy Targeting Myeloid-Derived Suppressor Cells (MDSCs) in Tumor Microenvironment.
Gao X; Sui H; Zhao S; Gao X; Su Y; Qu P
Front Immunol; 2020; 11():585214. PubMed ID: 33613512
[TBL] [Abstract][Full Text] [Related]
11. Targeted elimination of myeloid-derived suppressor cells via regulation of the STAT pathway alleviates tumor immunosuppression in neuroblastoma.
Xu W; Li S; Li M; Yang X; Xie S; Lin L; Li G; Zhou H
Immunol Lett; 2021 Dec; 240():31-40. PubMed ID: 34600949
[TBL] [Abstract][Full Text] [Related]
12. Significance of Immunosuppressive Cells as a Target for Immunotherapies in Melanoma and Non-Melanoma Skin Cancers.
Fujimura T; Aiba S
Biomolecules; 2020 Jul; 10(8):. PubMed ID: 32707850
[TBL] [Abstract][Full Text] [Related]
13. Hedgehog signaling promotes tumor-associated macrophage polarization to suppress intratumoral CD8+ T cell recruitment.
Petty AJ; Li A; Wang X; Dai R; Heyman B; Hsu D; Huang X; Yang Y
J Clin Invest; 2019 Dec; 129(12):5151-5162. PubMed ID: 31638600
[TBL] [Abstract][Full Text] [Related]
14. Disruption of tumour-associated macrophage trafficking by the osteopontin-induced colony-stimulating factor-1 signalling sensitises hepatocellular carcinoma to anti-PD-L1 blockade.
Zhu Y; Yang J; Xu D; Gao XM; Zhang Z; Hsu JL; Li CW; Lim SO; Sheng YY; Zhang Y; Li JH; Luo Q; Zheng Y; Zhao Y; Lu L; Jia HL; Hung MC; Dong QZ; Qin LX
Gut; 2019 Sep; 68(9):1653-1666. PubMed ID: 30902885
[TBL] [Abstract][Full Text] [Related]
15. Skewing the Th cell phenotype toward Th1 alters the maturation of tumor-infiltrating mononuclear phagocytes.
Nonaka K; Saio M; Suwa T; Frey AB; Umemura N; Imai H; Ouyang GF; Osada S; Balazs M; Adany R; Kawaguchi Y; Yoshida K; Takami T
J Leukoc Biol; 2008 Sep; 84(3):679-88. PubMed ID: 18566103
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of vascular adhesion protein-1 enhances the anti-tumor effects of immune checkpoint inhibitors.
Kinoshita T; Sayem MA; Yaguchi T; Kharma B; Morii K; Kato D; Ohta S; Mashima Y; Asamura H; Kawakami Y
Cancer Sci; 2021 Apr; 112(4):1390-1401. PubMed ID: 33453147
[TBL] [Abstract][Full Text] [Related]
17. Oncolytic Reovirus Inhibits Immunosuppressive Activity of Myeloid-Derived Suppressor Cells in a TLR3-Dependent Manner.
Katayama Y; Tachibana M; Kurisu N; Oya Y; Terasawa Y; Goda H; Kobiyama K; Ishii KJ; Akira S; Mizuguchi H; Sakurai F
J Immunol; 2018 Apr; 200(8):2987-2999. PubMed ID: 29555782
[TBL] [Abstract][Full Text] [Related]
18. GCN2 drives macrophage and MDSC function and immunosuppression in the tumor microenvironment.
Halaby MJ; Hezaveh K; Lamorte S; Ciudad MT; Kloetgen A; MacLeod BL; Guo M; Chakravarthy A; Medina TDS; Ugel S; Tsirigos A; Bronte V; Munn DH; Pugh TJ; De Carvalho DD; Butler MO; Ohashi PS; Brooks DG; McGaha TL
Sci Immunol; 2019 Dec; 4(42):. PubMed ID: 31836669
[TBL] [Abstract][Full Text] [Related]
19. Blockade of DC-SIGN
Hu B; Wang Z; Zeng H; Qi Y; Chen Y; Wang T; Wang J; Chang Y; Bai Q; Xia Y; Wang Y; Liu L; Zhu Y; Dai B; Guo J; Xu L; Zhang W; Xu J
Cancer Res; 2020 Apr; 80(8):1707-1719. PubMed ID: 32060149
[TBL] [Abstract][Full Text] [Related]
20. Tumor exosomes block dendritic cells maturation to decrease the T cell immune response.
Ning Y; Shen K; Wu Q; Sun X; Bai Y; Xie Y; Pan J; Qi C
Immunol Lett; 2018 Jul; 199():36-43. PubMed ID: 29800589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
